LiveWire

Many homebuilders stocks went from an oversold situation to a neutral one, with other ever reaching an oversold status. Source: Bespoke Investment

Several events justifies CureVac troubles to keep up with rivals. First, a brain haemorrhage forced the founder to step aside in march. Then, delays put the company months behind its rivals. Finally, its trials results revealed an overall efficacy of 48%, below the cut-off required. Source: Financial Times

Texas Instruments Inc. gave a revenue forecast for the current period that disappointed some investors, raising concerns that a jump in chip demand caused by the pandemic will be short-lived. The stock fell in extended trading. Sales will be $4.4 billion to $4.76 billion in the period ending in September, Texas Instruments said Wednesday in a statement. Profit will be $1.87 to $2.13 a share, the company said. On average, analysts predicted profit of $1.97 a share and sales of $4.59 billion. Source: Yahoo

Amazon, one of the main beneficiaries of pandemic-induced behavioral shifts that forced millions of Americans home last spring, has already seen two years of quarterly revenue growth. Revenue jumped 40.2% to $88.91 billion in the second quarter of 2020 on elevated customer demand that began in early March that year. Amazon's first-quarter 2021 revenue rose 43.8% to $108.52 billion, after a strong holiday season. Source: S&P Global

Verizon managed to top earnings expectations as promotions helped drive the 5G upgrade. Shares of the stock gained 0.7% on Wednesday following the results, as the company showed a record high in their number of new accounts subscribing to the unlimited plan. “Device upgrades, which were significantly higher compared to both second-quarter 2020 and 2019, drove 5G adoption and step-ups to premium unlimited plans, a strong indicator that our strategy is working,” said the CFO of the company. Source: MarketWatch